Medicare Enrolled
Dr. Ahmed Elnaggar, M.D.
Pulmonary Disease · Statesville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Elnaggar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Elnaggar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Elnaggar
Dr. Ahmed Elnaggar is a pulmonary disease specialist in Statesville, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Elnaggar performed 3,238 Medicare services across 2,170 unique beneficiaries.
Between the years covered by Open Payments, Dr. Elnaggar received a total of $6,712 from 38 pharmaceutical and/or device companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Elnaggar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in NC
$6,712 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,238
Medicare services
Top 7% in NC for pulmonary disease
2,170
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
392 | $10 | $49 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
375 | $85 | $167 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
263 | $1 | $3 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
261 | $27 | $124 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
255 | $39 | $109 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
247 | $38 | $109 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
229 | $92 | $177 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
203 | $159 | $500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
171 | $61 | $120 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $135 | $302 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
84 | $0 | $28 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
62 | $58 | $453 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
54 | $26 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
52 | $134 | $235 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
44 | $61 | $415 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
43 | $16 | $645 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
40 | $8 | $10 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
39 | $14 | $48 |
| Lung airway biopsy using endoscope A procedure to remove a small tissue sample from the lung airways using a flexible tube with a camera. The sample is examined to check for disease or abnormalities. |
36 | $119 | $675 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
33 | $454 | $1,538 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
32 | $7 | $29 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
30 | $431 | $1,139 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $101 | $214 |
| New patient office visit, complex (60-74 min) | 22 | $137 | $307 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
21 | $5 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
20 | $9 | $54 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $82 | $248 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
19 | $3 | $22 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $29 | $45 |
| Respiratory syncytial virus (RSV) immunoassay test A laboratory test that uses an immunoassay technique to detect the presence of respiratory syncytial virus in a sample. The results are determined through direct visual observation of the test reaction. |
17 | $13 | $60 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
15 | $72 | $81 |
| Low dose CT scan of chest for lung cancer screening A specialized CT scan of the chest using a lower radiation dose to screen for lung cancer. |
14 | $90 | $400 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
12 | $43 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,712
Total received (2018-2024)
Avg $959/year across 7 years
Top 27% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,712 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,547
2023
$516
2022
$487
2021
$560
2020
$576
2019
$1,723
2018
$1,303
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$352
AstraZeneca Pharmaceuticals LP
$248
Regeneron Healthcare Solutions, Inc.
$185
Actelion Pharmaceuticals US, Inc.
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
United Therapeutics Corporation
$89
Baxter Healthcare
$86
Grifols USA, LLC
$74
Takeda Pharmaceuticals U.S.A., Inc.
$52
Novartis Pharmaceuticals Corporation
$45
Mylan Specialty L.P.
$36
Vifor Pharma, Inc.
$29
AIMMUNE THERAPEUTICS, INC.
$23
ANI Pharmaceuticals, Inc.
$20
Inspire Medical Systems, Inc.
$17
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,185
GlaxoSmithKline, LLC.
$857
Boehringer Ingelheim Pharmaceuticals, Inc.
$850
Actelion Pharmaceuticals US, Inc.
$529
Sunovion Pharmaceuticals Inc.
$342
Novartis Pharmaceuticals Corporation
$301
Mylan Specialty L.P.
$290
ATRICURE, INC.
$276
United Therapeutics Corporation
$255
Regeneron Healthcare Solutions, Inc.
$199
Baxter Healthcare
$170
Genentech USA, Inc.
$161
AtriCure, Inc.
$145
Philips Electronics North America Corporation
$135
Grifols USA, LLC
$115
Mallinckrodt LLC
$94
Resmed Corp
$89
Bayer Healthcare Pharmaceuticals Inc.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$77
Merck Sharp & Dohme Corporation
$76
Insmed, Inc.
$54
Gilead Sciences, Inc.
$50
ANI Pharmaceuticals, Inc.
$41
Circassia Pharmaceuticals Inc
$41
Mallinckrodt Enterprises LLC
$37
Lilly USA, LLC
$34
Vifor Pharma, Inc.
$29
Eisai Inc.
$25
AIMMUNE THERAPEUTICS, INC.
$23
Inogen, Inc.
$22
GENZYME CORPORATION
$21
Insulet Corporation
$21
Nabriva Therapeutics, plc
$18
Shire North American Group Inc
$17
Inspire Medical Systems, Inc.
$17
Amgen Inc.
$14
PFIZER INC.
$13
Ceribell, Inc.
$11
Top 3 companies account for 43.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · Adempas · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · DreamStat Cpap Auto · ELIQUIS · FARXIGA · FASENRA · GLASSIA · HUMULIN · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · InogenOne · LONHALA MAGNAIR · NIOX VERO · NUCALA · None · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Omnipod · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · Respiratoriy Care Undiv · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNERGY ABLATION SYSTEM · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · Wellcentive Undiv · XOLAIR · Xenleta · Xolair · YUPELRI · Yupelri · ZENPEP · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
5
Per 100K population
2.6
County median income
$78,678
Nearest hospital
IREDELL MEMORIAL HOSPITAL INC
9.3 mi
9.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Elnaggar is a mixed practice specialist, with above-average Medicare volume (top 7% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Elnaggar experienced with drug injection, under skin or into muscle?
Based on Medicare claims data, Dr. Elnaggar performed 392 drug injection, under skin or into muscle services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Elnaggar receive payments from pharmaceutical companies?
Yes. Dr. Elnaggar received a total of $6,712 from 38 companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Elnaggar's costs compare to other pulmonary diseases in Statesville?
Dr. Elnaggar's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Elnaggar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Statesville
Browse pulmonary diseases in Statesville ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NC
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NC
Which NC pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology